Xuli Wu

463 total citations
7 papers, 380 citations indexed

About

Xuli Wu is a scholar working on Molecular Biology, Pharmacology and Nephrology. According to data from OpenAlex, Xuli Wu has authored 7 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Nephrology. Recurrent topics in Xuli Wu's work include Inflammatory mediators and NSAID effects (2 papers), Acute Kidney Injury Research (2 papers) and vaccines and immunoinformatics approaches (1 paper). Xuli Wu is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Acute Kidney Injury Research (2 papers) and vaccines and immunoinformatics approaches (1 paper). Xuli Wu collaborates with scholars based in United States, China and India. Xuli Wu's co-authors include James P. Kehrer, Zhimin Tong, Ching-Shih Chen, Dmitriy Ovcharenko, Jiuxiang Zhu, Kaushik Datta, Shyam Biswal, George K. Acquaah-Mensah, Young Eun Choi and Xianmei Yang and has published in prestigious journals such as Biochemical Journal, International Journal of Environmental Research and Public Health and Toxicology.

In The Last Decade

Xuli Wu

7 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuli Wu United States	7	201	81	55	48	33	7	380
Yanqing Chi China	13	259 1.3×	134 1.7×	23 0.4×	29 0.6×	36 1.1×	23	577
Jinzhao He China	13	280 1.4×	110 1.4×	85 1.5×	23 0.5×	30 0.9×	19	546
Mandy Fechner Germany	10	155 0.8×	50 0.6×	12 0.2×	38 0.8×	28 0.8×	10	361
Yuming Huang China	13	228 1.1×	49 0.6×	98 1.8×	98 2.0×	58 1.8×	25	580
Amanda Garza United States	13	246 1.2×	30 0.4×	39 0.7×	59 1.2×	42 1.3×	28	588
Rui Yan China	11	224 1.1×	62 0.8×	46 0.8×	104 2.2×	45 1.4×	36	446
Wendell-Lamar B. Blackwell United States	8	176 0.9×	19 0.2×	45 0.8×	26 0.5×	45 1.4×	8	458
Xia Zhong China	10	150 0.7×	89 1.1×	30 0.5×	23 0.5×	47 1.4×	24	359
Xiaoqiang Geng China	11	196 1.0×	82 1.0×	67 1.2×	18 0.4×	23 0.7×	15	389

Countries citing papers authored by Xuli Wu

Since Specialization

Citations

This map shows the geographic impact of Xuli Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuli Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuli Wu more than expected).

Fields of papers citing papers by Xuli Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuli Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuli Wu. The network helps show where Xuli Wu may publish in the future.

Co-authorship network of co-authors of Xuli Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuli Wu. A scholar is included among the top collaborators of Xuli Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuli Wu. Xuli Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Zhang, Haiping, Konda Mani Saravanan, Yanjie Wei, et al.. (2023). Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening. Journal of Chemical Information and Modeling. 63(3). 835–845. 40 indexed citations

2.

Gao, Kaiping, Jinjin Wang, Linlin Li, et al.. (2016). Polymorphisms in Four Genes (KCNQ1 rs151290, KLF14 rs972283, GCKR rs780094 and MTNR1B rs10830963) and Their Correlation with Type 2 Diabetes Mellitus in Han Chinese in Henan Province, China. International Journal of Environmental Research and Public Health. 13(3). 260–260. 29 indexed citations

3.

Tong, Zhimin, Xuli Wu, Ching-Shih Chen, & James P. Kehrer. (2006). Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells. Lung Cancer. 52(1). 117–124. 18 indexed citations

4.

Tong, Zhimin, Xuli Wu, Dmitriy Ovcharenko, et al.. (2005). Neutrophil gelatinase-associated lipocalin as a survival factor. Biochemical Journal. 391(2). 441–448. 155 indexed citations

5.

Yang, Xianmei, et al.. (2004). Effect of acrolein and glutathione depleting agents on thioredoxin. Toxicology. 204(2-3). 209–218. 40 indexed citations

6.

Tong, Zhimin, Xuli Wu, & James P. Kehrer. (2003). Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochemical Journal. 372(1). 203–210. 42 indexed citations

7.

Biswal, Shyam, George K. Acquaah-Mensah, Kaushik Datta, Xuli Wu, & James P. Kehrer. (2002). Inhibition of Cell Proliferation and AP-1 Activity by Acrolein in Human A549 Lung Adenocarcinoma Cells Due to Thiol Imbalance and Covalent Modifications. Chemical Research in Toxicology. 15(2). 180–186. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact